Ivanhoe et al Angioplasty of Chronic Total Occlusion 107
Emory University Hospital, Atlanta, Ga., between 1980 and 1988. Patients having had a prior revascularization procedure (angioplasty or coronary surgery) or myocardial infarction within 10 days of angioplasty were excluded. There were 480 patients in the study population.
Definitions
Total occlusion was defined as 100% preangioplasty diameter narrowing with either TIMI The presence of an intracoronary thrombus was determined by review of 256 angiograms that were available, by three of the authors (M.F., G.G., R.I.). A thrombus was considered to be present, separate from the total occlusion point, if there was an intraluminal filling defect (contrast opacifies either side of the filling defect) or circumscribed inhomogeneous filling of the artery. This applied to both the pre-and postangioplasty angiograms. The presence of an entry port at the site of total occlusion was determined by a tapering of the vessel at the occluded segment rather than an abrupt cutoff. The percent diameter stenosis was determined by measuring the minimum stenosis diameter compared with the normal-appearing adjacent segment in two views by using electronic digital calipers (Sandhill) previously validated against quantitative angiography.1213 Measurements were expressed as the mean of two angiographic projections. The duration (in time) of the total occlusion and the length of the occluded segment were not available and could not be ascertained reliably in this relatively large series.
Angina was classified according to the Canadian Cardiovascular Society.14 Congestive failure was classified according to New York Heart Association classification.
The angioplasty was considered a procedural success if the percent diameter stenosis of the first dilated total occlusion was reduced to less than 50% and antegrade flow showed normal runoff. Clinical success required procedural success and the absence of in-hospital complications of myocardial infarction, coronary surgery, or death. Restenosis was defined as a greater than 50% diameter stenosis at follow-up angiogram of the first dilated total occlusion. Reocclusion was defined as recurrent total occlusion of the first dilated total occlusion. Using these definitions, the per patient and per lesion rates of success, restenosis, and reocclusion were the same.
Follow-up
Angiographic follow-up was routinely recommended at 6 months, or earlier in the presence of symptoms. Clinical follow-up was obtained by trained personnel who made telephone contact with patients in the study. These personnel are instructed in determining cause of death, especially whether death is cardiovascular in nature, and in diagnosing and grading angina pectoris. Patients were asked about the presence of symptoms, all hospitalizations subsequent to the index angioplasty, and repeat angioplasty or coronary surgery. All deaths were recorded and coded as cardiac or noncardiac when the information was available. Clinical follow-up was available in 95% of the cases. All subsequent revascularization procedures at the Emory University hospitals are also captured from the clinical data base.
Statistical Analysis
The study population was grouped by both angiographic and clinical success or failure. The resultant groups were compared by age, sex, hypertension, diabetes, previous myocardial infarction, and angina class. The groups were further compared for procedural and clinical outcome based on ejection fraction, extent of coronary artery disease, presence of functional occlusion, thrombus, and an entry port at the site of occlusion. The groups were also compared for procedural data and complications including the vessel dilated, total number of sites dilated, number of vessels dilated, postprocedure Q wave myocardial infarction, postangioplasty coronary surgery, and inhospital death.
To evaluate parameters affecting restenosis of 332 clinically successful angioplasty procedures, we analyzed the data in 175 patients who had angiographic follow-up available for review (53%). The patients were divided into those with continued success and those with restenosis. The subgroup with reocclusion was also analyzed. The clinical angiographic and procedural variables noted above were considered in these subgroups. Restenosis and reocclusion rates were determined for subgroups defined by the presence or absence of the angiographic parameters functional occlusion, thrombus, and entry port. Table 2 . The ejection fractions were largely normal despite the frequency of previous myocardial infarctions by history. There was no difference in ejection fraction between the groups. One-vessel disease was most common, with a higher prevalence in the successful group. Angiographic and clinical success were more common in patients with slight antegrade flow beyond the occlusion and in patients who had an entry port at the angioplasty site. Data concerning functional occlusions, thrombi at the dilatation site, and an entry port were available on 256 patients whose angioplasty angiograms were available for review.
Procedural Data and Complications
Procedural data and complications for all 480 patients and the angiographic and clinically determined subgroups are displayed in Table 3 . Multiple-site dilatations were not correlated with an unsuccessful procedure. The 12 patients undergoing multiple total occlusion angioplasties had the highest rate of angiographic and clinical success. This is not as surprising as it would initially seem because the second total occlusion would only be attempted if the first was successfully dilated. Figure 3 . Most referrals to coronary surgery occurred within 8 months after angioplasty in both groups. Referral to coronary surgery tended to take place immediately after the procedure in the failed group with very little surgery occurring thereafter. In the clinically successful group, referral to coronary surgery occurred sporadically over the first 8 months. At 4 years, freedom from coronary surgery was 87% in the clinically successful group and 64% in the clinical failures. The data on presence or absence of angina pectoris were available in 427 patients at the time of follow-up 35±22 months after the procedure ( Table 7) . The presence or absence of angina was noted in the total population and in patients with clinically successful and unsuccessful procedures. Of these 427 patients, 284 (66.5%) remained free of angina. The difference at follow-up between those with successful and unsuccessful initial angioplasty procedures did not reach significance. A larger difference may have been blunted by the fact that more unsuccessful patients were revascularized by coronary bypass surgery. Discussion In this study, the predictors of success, the restenosis rate, and the long-term clinical outcome of patients undergoing angioplasty of a chronically occluded vessel are presented. A total of 480 patients undergoing angioplasty from 1980 through 1988 were evaluated based on angiographic and clinical profiles.
The number of vessels diseased, site location, and absence of a functional occlusion were correlates of angiographic and clinical outcomes. These findings support and extend presently held knowledge regarding the outcome of patients with total occlusion undergoing angioplasty.3-11 Our findings corroborate the relatively high restenosis rate recently reported in the literature.89 However, total reocclusion occurs much less frequently than restenosis. These data also show no continuing restenosis after the first 10 months.
Long-term clinical outcome after an attempt at angioplasty of a chronically occluded vessel over 4 a successful angioplasty). This parameter was not prospectively recorded in most of these patients. The present study plus the available literature on totally occluded segments reveal that the angioplasty success rate will be higher if the following anatomical characteristics exist: 1) There is some flow into the occlusion or just beyond, 2) there is an entry port at the site of occlusion so that a specific direction leading to the distal lumen is evident, 3) there is a short segment of occlusion based on analysis of collateral flow, 4) the total occlusion is a relatively recent event, or 5) bridging collaterals from the proximal segment to the area beyond the lesion are absent. In the present study, a thrombus may be a marker for a short period of occlusion. The restenosis rate after angioplasty of total occlusions has varied from 45%9 to 65%.10 The 54% restenosis or reocclusion rate in the present study is consistent with these rates. In addition, total reocclusion occurred just half as often as restenosis without reocclusion. A recent analysis found that the prevalence of restenosis increased in patients studied at 12 months after angioplasty compared with those studied at 6 months.8 Although restenosis may occur before the date of angiographic observation, our data clearly show that after 10 months, there is little or no further restenosis. The present observations are weakened because the restudy rate is only 53%. However, 34 patients had their only angiographic follow-up well beyond 10 months and almost no late restenosis was noted. No factors studied to date have reliably predicted restenosis, but we did note that restenosis occurred more frequently in the few patients with a thrombus at the site of the lesion. In addition, reocclusion was less common in patients with functional occlusion before angioplasty.
Sustained clinical success has been reported in several smaller studies.9-11 The present study adds to these studies by providing a larger patient population and extending follow-up to 4 years. Our results highlight the durability of clinical success with favorable long-term survival. Furthermore, patients having a clinically successful angioplasty of a chronic occlusion rarely suffered myocardial infarction or death over 4 years, and only a small minority required coronary surgery. Most events occurred in the early follow-up period. Those with clinical success remained relatively free of cardiac events in the latter 3 years of follow-up. The good survival and relatively low event rates after successful recanalization of chronic occlusion presented here suggest that angioplasty, is effective in some patients with chronically occluded vessels and viable myocardium distal to the occluded vessel.
We have shown that there are specific factors that predict angiographic and clinical success in angioplasty of chronic occlusion. Although angioplasty of a chronic occlusion in the absence of an entry port or functional occlusion is technically more challenging (with a lower rate of success), selected patients may benefit, and the complication rate is acceptable.
However, angioplasty of total occlusions should not be viewed as perfectly safe: There was a 1% mortality and 2% myocardial infarction rate. Myocardial infarction may occur in this setting due to isoembolism, side branch closure, or acute reocclusion in a previously collateral dependent zone. For this procedure to provide maximum benefit, there should be careful case selection with consideration of symptoms and viable myocardium that is potentially ischemic or hibernating. Case selection will also be determined by the probability of achieving success and the longterm prognosis. The development of methods to improve success rates for angioplasty of chronically occluded vessels will expand the patient population that may benefit from this procedure.
